AU5801896A - Antigen-specific activation of unprimed cd8+ t cells - Google Patents

Antigen-specific activation of unprimed cd8+ t cells

Info

Publication number
AU5801896A
AU5801896A AU58018/96A AU5801896A AU5801896A AU 5801896 A AU5801896 A AU 5801896A AU 58018/96 A AU58018/96 A AU 58018/96A AU 5801896 A AU5801896 A AU 5801896A AU 5801896 A AU5801896 A AU 5801896A
Authority
AU
Australia
Prior art keywords
unprimed
antigen
cells
specific activation
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58018/96A
Inventor
Marloes L. H. Debruijn
Michael R. Jackson
Per A Peterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU5801896A publication Critical patent/AU5801896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU58018/96A 1995-05-23 1996-05-22 Antigen-specific activation of unprimed cd8+ t cells Abandoned AU5801896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US447761 1989-12-08
US44776195A 1995-05-23 1995-05-23
PCT/US1996/007436 WO1996037107A1 (en) 1995-05-23 1996-05-22 Antigen-specific activation of unprimed cd8+ t cells

Publications (1)

Publication Number Publication Date
AU5801896A true AU5801896A (en) 1996-12-11

Family

ID=23777643

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58018/96A Abandoned AU5801896A (en) 1995-05-23 1996-05-22 Antigen-specific activation of unprimed cd8+ t cells

Country Status (2)

Country Link
AU (1) AU5801896A (en)
WO (1) WO1996037107A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
AU2001267349A1 (en) * 2000-04-14 2001-10-30 Cistem Biotechnologies Gmbh Pharmaceutical preparations comprising modified peptides
ES2329453T3 (en) * 2001-05-15 2009-11-26 Ortho Mcneil Janssen Pharm EX-VIVAL PRIMING TO GENERATE SPECIFIC CYTOTOXY T LYMPHOCYTES OF THE CD40 LINK TO TREAT AUTOIMMUNITARY AND ALLERGIC DISEASES.
WO2014179132A1 (en) 2013-04-29 2014-11-06 The Board Of Trustees Of The Leland Stanford Junior University Use of anti-cd47 agents to enhance immunization
WO2017102921A1 (en) * 2015-12-16 2017-06-22 Tcer Ab T-cell reactivity platform

Also Published As

Publication number Publication date
WO1996037107A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
AU660404B3 (en) Solar power system
AU4609296A (en) Improved isolation system and gravel pack assembly and uses thereof
AU7250596A (en) Initiator system and adhesive composition made therewith
AU6177796A (en) Initiator system and adhesive composition made therewith
AU4917396A (en) Electrical and structural interconnector
AU5730896A (en) Fucosyltransferase genes and uses thereof
AU7612196A (en) Functional human hematopoietic cells
AU6496696A (en) Junction of power cables
AU7979098A (en) Complete activation of mammalian oocytes
AU5751398A (en) Antigen-specific igm detection
AU7010996A (en) Selective elimination of t cells that recognize specific preselected targets
AU5893296A (en) Solar cell system and method of establishing the system
AU1555297A (en) Antigenic modulation of cells
AU7420396A (en) Building structure
AU2578195A (en) Power generating system using buoyancy
AU2682895A (en) EG Cells of Ungulates
AU5801896A (en) Antigen-specific activation of unprimed cd8+ t cells
AU6580498A (en) Partition feeder and method
AU1524095A (en) Ex vivo activation of immune cells
AU1278897A (en) Passification of zinc surfaces
AU2814897A (en) Method of isolating regulators of t cell activation
AU1294897A (en) Power line audio system
AU5552996A (en) Purified mammalian t cell antigen crtam
AU7035198A (en) Method of detecting antigen-specific t-cells
AU4946496A (en) Collector of solar energy